Clinical Trial: A Study to Investigate Pharmacokinetics (PK), Safety, and Tolerability of VH4367310 in Healthy Adult Participants

U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07818915) titled 'A Study to Investigate Pharmacokinetics (PK), Safety, and Tolerability of VH4367310 in Healthy Adult Participants' on Sept. 08.

Brief Summary: This study evaluates the PK, safety, and tolerability of a single increasing dose of VH4367310, a cabotegravir (CAB) prodrug, when administered intramuscularly in healthy adult participants 18 to 55 years of age.

Study Start Date: Sept. 15

Study Type: INTERVENTIONAL

Condition: HIV Infections

Intervention: DRUG: VH4367310

VH4367310 will be administered intramuscularly.

DRUG: Placebo

Placebo will be administered intramuscularly.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: ViiV H...